Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediates. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN118126005B reveals a metal-free route for fluorinated heterocycles. This method offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN115353511A details a safe, one-pot palladium-catalyzed carbonylation method for synthesizing complex biheterocycles, offering significant cost and safety advantages.
Patent CN111675662B reveals a cost-effective iron-catalyzed route for 2-trifluoromethyl quinazolinones, offering reliable supply chain solutions for API intermediates.
Patent CN110028394B details a novel Pd-catalyzed carbonylation for indanones. This method offers cost reduction in API manufacturing and streamlined supply chains.
Patent CN113045489B reveals a novel Pd-catalyzed route to quinolinones using benzisoxazole, offering cost-effective API intermediate manufacturing.
Patent CN111423381B reveals a mild Pd-catalyzed carbonylation route for 2-trifluoromethyl imidazoles, offering high yields and scalable production for reliable pharmaceutical intermediate suppliers.
Patent CN114409515A reveals a metal-free route to gem-difluoroolefins using diphenylphosphine oxide. Offers mild conditions and high purity for pharma intermediates.
Patent CN110183378A reveals a novel copper-catalyzed route for high-purity nicotinamide derivatives, offering significant supply chain and cost advantages.
Patent CN113880781B reveals glucose-based synthesis for trifluoromethyl triazoles. Offers mild conditions, biomass sourcing, and scalable manufacturing for pharmaceutical intermediates.
Novel nickel-catalyzed carbonylation method for indoles. High efficiency, broad substrate scope. Ideal for API intermediates.
Patent CN113089006B details a catalyst-free electrochemical route for 4-seleno-1H-pyrazoles, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel Pd-catalyzed carbonylation route for 2,3-dihydroquinolones. Enhanced purity, scalable process, cost-effective manufacturing for pharmaceutical intermediates.
Patent CN117164534A enables efficient Pd-catalyzed route. Cost reduction in pharmaceutical intermediates manufacturing. High-purity benzofuran derivatives available.
Novel water-phase iodine-mediated synthesis of indolo[2,3-b]quinolines. Eliminates organic solvents and base additives. High yield, scalable, cost-effective pharmaceutical intermediate manufacturing.
Patent CN113307790B reveals a metal-free oxidative cyclization for triazoles. This method offers significant cost reduction and simplified supply chain for API manufacturing.
Patent CN108690007B details a transition metal-catalyzed C-H coupling method using ionic liquids for efficient ortho-cyanation, offering significant cost reduction in API manufacturing.
Novel Pd-catalyzed carbonylation method for 2-CF3 imidazoles. High yield, mild conditions, scalable process for pharmaceutical intermediates.
Novel iodine-promoted method using DMF as carbon source for 3-CF3-1,2,4-triazoles. Enhances supply chain reliability and reduces manufacturing costs for API intermediates.
Novel oxidative cyclization method for 1,2,4-triazole intermediates. Metal-free catalysis ensures cost reduction and scalable supply for pharmaceutical manufacturing.
Novel iridium-catalyzed synthesis offers high purity and cost efficiency for pharmaceutical intermediates. Enhances supply chain reliability for anti-colon cancer drug development.